WHEW, we’re entering triple digits now, are we? Well, in any case, thank you for sticking along with the ride — whether you’ve been here the whole time, reading along since Weekly Newsletter #1, or whether this is your first time reading The Burgundy Zine. We appreciate you, bug buddies.
Summer’s over but the coronavirus pandemic appears to have no end in sight. Case numbers are still on the rise, schools change their plans for reopening every other day, social injustice continues to take more victims, and 10.2 percent of Americans remain unemployed.
Oh, let’s not forget to mention there’s an incredibly important presidential election looming over our nation, too.
Needless to say, 2020 has left us in a global fugue, confined to our homes and a prisoner of our minds, using moods like chalk to tally down the days spent in quarantine. After all, the varying emotions seem to be the only way to tell the days apart anymore.
Last week, the National Institutes of Health announced that AI technology is underway to aid physicians across the United States in the global war against COVID-19.
Recently, we spoke to NIBIB/NIH Director of Research Sciences Krishna Kandarpa, M.D., P.h.D. via email to learn more about the development of this technology and how it could impact the future of radiology.
Despite the recent spike in coronavirus cases, a glimmer of hope shines in from two recent National Institutes of Health press releases.
First, the NIH says placentas lack major molecules used by COVID-19 to cause an infection. This may explain why it’s (thankfully) very rare to see fetuses and newborns contracting the virus from infected pregnant mothers.
Second, the first phase of an NIH-sponsored COVID-19 vaccine appears to safely generate an immune response in healthy adults.